VFEND for Pulmonary mycosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where VFEND was used for Pulmonary mycosis.
Most Reported Side Effects for VFEND
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 11 | 6.0% | 11 | 2 |
| Leukaemia | 9 | 5.0% | 7 | 2 |
| Acute myeloid leukaemia | 7 | 3.9% | 4 | 3 |
| Hallucination | 7 | 3.9% | 0 | 4 |
| Off label use | 7 | 3.9% | 2 | 2 |
| Pneumonia | 7 | 3.9% | 2 | 5 |
| Visual impairment | 7 | 3.9% | 0 | 0 |
| Thrombocytopenia | 6 | 3.3% | 3 | 3 |
| Drug ineffective | 5 | 2.8% | 1 | 2 |
| Hypersensitivity | 5 | 2.8% | 0 | 0 |
| Liver function test abnormal | 5 | 2.8% | 0 | 2 |
| Malaise | 5 | 2.8% | 0 | 2 |
| Neutropenia | 5 | 2.8% | 0 | 2 |
| Septic shock | 5 | 2.8% | 4 | 1 |
Other Indications for VFEND
Aspergillus infection (29)
Bronchopulmonary aspergillosis (17)
Fungal infection (10)
Pneumonia fungal (5)
Product used for unknown indication (5)
Other Drugs Used for Pulmonary mycosis
VORICONAZOLE (131)
ITRACONAZOLE (33)
AMPHOTERICIN B (23)
POSACONAZOLE (12)
CASPOFUNGIN (8)
TERBINAFINE (8)